Therapy-related acute leukemia

Clinics in Laboratory Medicine

Volumn 20, Issue 1, 2000, Pages 71-81

  Karp, J E ^a   Sarkodee Adoo, C B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; GLYCOPROTEIN P; MELPHALAN; PIPERAZINE DERIVATIVE; PROCARBAZINE; VALSPODAR; VERAPAMIL; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA ALKYLATION; DRUG CARCINOGENICITY; DRUG EFFICACY; DRUG INDUCED CANCER; HUMAN; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0033998719     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30077-5     Document Type: Review

References (57)

1. Aguiar R.C. Therapy-related chronic myeloid leukemia: An epidemiological, clinical and pathogenetic appraisal [published erratum appears in Leuk Lymphoma 30(5-6):665, 1998] Leuk Lymphoma 29 1—2 1998 17
2. Alcalay M. Zangrilli D. Pandolfi P.P. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus Proc Natl Acad Sci U S A 88 1991 1977
3. Apian P.D. Chervinsky D.S. Stanulla M. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors Blood 87 1996 2649
4. Aviles A. Diaz-Maqueo J.C. Ayala J.R. Hodgkin’s disease and acute leukemia. Is it a true association? Arch Med Res 23 1992 65
5. Berman E. Strife A. Wisniewski D. Duration of the preclinical phase of chronic myelogenous leukemia: A case report Blood 78 1991 2969
6. Bokemeyer C. Schmoll H.J. Treatment of testicular cancer and the development of secondary malignancies J Clin Oncol 13 1995 283
7. Broeker P.L. Super H.G. Thirman M.J. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites Blood 87 1996 1912
8. Chen C.L. Fuscoe J.C. Liu Q. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide J Natl Cancer Inst 88 1996 1840
9. Cimino G. Rapanotti M.C. Biondi A. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Res 57 1997 2879
10. Corso A. Lazzarino M. Morra E. Chronic myelogenous leukemia and exposure to ionizing radiation—a retrospective study of 443 patients Ann Hematol 70 1995 79
11. Dabaja B.S. Faderl S. Thomas D. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: Incidence, associations and implications Leukemia 13 1999 869
12. Dastugue N. Pris J. Colombies P. Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera Cancer Genet Cytogenet 44 1990 275
13. Foroni L. Boehm T. Lampert F. Multiple methylation-free islands flank a small breakpoint cluster region on 11p13 in the t(11;14)(p13;q11) translocation Genes Chromosomes Cancer 1 1990 301
14. Geller R.B. Vogelsang G.B. Wingard J.R. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin’s disease J Clin Oncol 6 1988 1558
15. Grant B. Trombley L. Nicklas J. Mutation at hprt in CD34 + cells from patients at risk for AML Blood 88 suppl 1 1996 83a
16. Hart S.M. Ganeshaguru K. Hoffbrand A.V. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia Leukemia 8 1994 2163
17. Hernandez J.M. Mecucci C. Michaux L. del(7q) in chronic B-cell lymphoid malignancies Cancer Genet Cytogenet 93 1997 147
18. Kaldor J.M. Day N.E. Clarke E.A. Leukemia following Hodgkin’s disease N Engl J Med 322 1990 7
19. Karp J. Sarkodee-Adoo C. Acute progranulocytic leukemia: A model for molecular medicine Emerging Therapeutic Targets 3 1999 135
20. Karp J.E. Smith M.A. Modifying risks of secondary leukemias: Is drug scheduling important? [editorial] J Natl Cancer Inst 88 1996 1787
21. Kauppi M.J. Savolainen H.A. Anttila V.J. Increased risk of leukaemia in patients with juvenile chronic arthritis treated with chlorambucil Acta Paediatr 85 1996 248
22. Kerim S. Mecucci C. Cuneo A. 5q-anomaly in lymphoid disorders Leukemia 4 1990 12
23. Knutsen T. Cytogenetic changes in the progression of lymphoma Leuk Lymphoma 31 1998 1
24. Kollmannsberger C. Beyer J. Droz J.P. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors J Clin Oncol 16 1998 3386
25. Kudo K. Yoshida H. Kiyoi H. Etoposide-related acute promyelocytic leukemia Leukemia 12 1998 1171
26. Kwong Y.L. Au W.Y. Liang R.H. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: Association with -7/7q Cancer Genet Cytogenet 104 1998 94
27. Leith C.P. Chen I.M. Kopecky K.J. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR-/efflux + and MDR1 +/efflux-cases Blood 86 1995 2329
28. Leith C.P. Kopecky K.J. Godwin J. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study Blood 89 1997 3323
29. Lesesve J.F. Schneider P. Dolgopolov I. Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing’s sarcoma Med Pediatr Oncol 29 1997 132
30. Litz C.E. Etzell J. Aberrant DNA methylation of genomic regions translocated in myeloid malignancies Leuk Lymphoma 30 1998 1
31. Mather E.L. Perry R.P. Methylation status and DNase I sensitivity of immunoglobulin genes: Changes associated with rearrangement Proc Natl Acad Sci USA 80 1983 4689
32. Merlat A. Lai J.L. Sterkers Y. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases Leukemia 13 1999 250
33. Michieli M. Damiani D. Ermacora A. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications Br J Haematol 104 1999 328
34. Moloney W.C. Radiogenic leukemia revisited Blood 70 1987 905
35. Morrison V. Rai K. Peterson B. Therapy-related myelodysplastic syndrome (T-MDS) or acute myeloid leukemia (T-AML) in patients with chronic lymphocytic leukemia (CLL) treated with chlorambucil, fludarabine, or fludarabine plus chlorambucil. An intergroup study (CALGB 9011) [abstract] Proceedings of the American Society of Clinical Oncology 18 1999 9a
36. Najean Y. Deschamps A. Dresch C. Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow-up Cancer 61 1988 89
37. Nakayama M. Wada M. Harada T. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias Blood 92 1998 4296
38. Nucifora G. Birn D.J. Espinosa R.D. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis Blood 81 1993 2728
39. Pedersen-Bjergaard J. Brondum-Nielsen K. Karle H. Chemotherapy-related-late occurring-Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia 11 1997 1571
40. Petridou E. Trichopoulos D. Dessypris N. Infant leukaemia after in utero exposure to radiation from Chernobyl Nature 382 6589 1996 352
41. Pui C.H. Relling M.V. Behm F.G. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins Leukemia 9 1995 1680
42. Pui C.H. Ribeiro R.C. Hancock M.L. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia N Engl J Med 325 1991 1682
43. Rosner F. Grunwald H. Hodgkin’s disease and acute leukemia. Report of eight cases and review of the literature Am J Med 58 1975 339
44. Roulston D. Espinosa R. 3rd Nucifora G. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: Association with prior therapy Blood 92 1998 2879
45. Rubin C.M. Larson R.A. Bitter M.A. Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia Blood 70 1987 1338
46. Savitsky K. Ziv Y. Bar-Shira A. A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23 Genomics 33 1996 99
47. Smith P.G. Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays BMJ 284 6314 1982 449
48. Stanulla M. Wang J. Chervinsky D.S. Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus Leukemia 11 1997 490
49. Strissei P.L. Strick R. Rowley J.D. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region Blood 92 1998 3793
50. Sugita K. Furukawa T. Tsuchida M. High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin’s lymphoma Am J Pediatr Hematol Oncol 15 1993 99
51. Tasak T. Lee S. Spira S. Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia Leuk Res 20 1996 113
52. Tasaka T. Lee S. Spira S. Microsatellite instability during the progression of acute myelocytic leukaemia Br J Haematol 98 1997 219
53. Tauchi T. Ohyashiki J.H. Ohyashiki K. Methylation status of T-cell receptor beta-chain gene in B precursor acute lymphoblastic leukemia: Correlation with hypomethyl-ation and gene rearrangement Cancer Res 51 1991 2917
54. Uchida N. Combs J. Chen S. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities Blood 88 1996 1297
55. Van den Berghe H. Michaux L. 5q-, twenty-five years later: A synopsis Cancer Genet Cytogenet 94 1997 1
56. Weiss H.A. Darby S.C. Fearn T. Leukemia mortality after X-ray treatment for ankylosing spondylitis Radiat Res 142 1995 1
57. Yoshida H. Naoe T. Fukutani H. Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: Sequence non-specific recombination between the PML and RARA genes within identical short stretches Genes Chromosomes Cancer 12 1995 37